chrX-18827401-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001377996.1(PPEF1):āc.1876A>Gā(p.Ile626Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000184 in 1,208,980 control chromosomes in the GnomAD database, including 2 homozygotes. There are 83 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00011 ( 0 hom., 3 hem., cov: 23)
Exomes š: 0.00019 ( 2 hom. 80 hem. )
Consequence
PPEF1
NM_001377996.1 missense
NM_001377996.1 missense
Scores
1
4
12
Clinical Significance
Conservation
PhyloP100: 8.79
Genes affected
PPEF1 (HGNC:9243): (protein phosphatase with EF-hand domain 1) This gene encodes a member of the serine/threonine protein phosphatase with EF-hand motif family. The protein contains a protein phosphatase catalytic domain, and at least two EF-hand calcium-binding motifs in its C terminus. Although its substrate(s) is unknown, the encoded protein has been suggested to play a role in specific sensory neuron function and/or development. This gene shares high sequence similarity with the Drosophila retinal degeneration C (rdgC) gene. Several alternatively spliced transcript variants, each encoding a distinct isoform, have been described. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.022283405).
BS2
High Hemizygotes in GnomAd4 at 3 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PPEF1 | NM_001377996.1 | c.1876A>G | p.Ile626Val | missense_variant | 16/16 | ENST00000470157.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PPEF1 | ENST00000470157.2 | c.1876A>G | p.Ile626Val | missense_variant | 16/16 | 3 | NM_001377996.1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000107 AC: 12AN: 112281Hom.: 0 Cov.: 23 AF XY: 0.0000872 AC XY: 3AN XY: 34417
GnomAD3 genomes
AF:
AC:
12
AN:
112281
Hom.:
Cov.:
23
AF XY:
AC XY:
3
AN XY:
34417
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000180 AC: 33AN: 183455Hom.: 0 AF XY: 0.000147 AC XY: 10AN XY: 67899
GnomAD3 exomes
AF:
AC:
33
AN:
183455
Hom.:
AF XY:
AC XY:
10
AN XY:
67899
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000191 AC: 210AN: 1096646Hom.: 2 Cov.: 29 AF XY: 0.000221 AC XY: 80AN XY: 362056
GnomAD4 exome
AF:
AC:
210
AN:
1096646
Hom.:
Cov.:
29
AF XY:
AC XY:
80
AN XY:
362056
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000107 AC: 12AN: 112334Hom.: 0 Cov.: 23 AF XY: 0.0000870 AC XY: 3AN XY: 34480
GnomAD4 genome
AF:
AC:
12
AN:
112334
Hom.:
Cov.:
23
AF XY:
AC XY:
3
AN XY:
34480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
26
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 29, 2024 | The c.1876A>G (p.I626V) alteration is located in exon 19 (coding exon 16) of the PPEF1 gene. This alteration results from a A to G substitution at nucleotide position 1876, causing the isoleucine (I) at amino acid position 626 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;T
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;D;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
M;.;.
MutationTaster
Benign
D;D;D;D;N
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N
REVEL
Uncertain
Sift
Benign
T;T;T
Sift4G
Benign
T;T;D
Polyphen
D;D;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at